Shiatsu Adjuvant Therapy And Placebo For Schizophrenia

Herzog Hospital

Status: Unknown

Conditions: Schizophrenia

Treatments: Behavioral: Acupressure adjuvant therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00788970

lichtenberg3

Details and patient eligibility

About

In the current study we will study the effect of adding acupressure (shiatsu) to conventional therapy in treating individuals with schizophrenia.

Full description

Acupressure, also known as shiatsu, is a holistic form of medicine originating in Japan but now widely practiced throughout the world. The theory is based on Traditional Chinese Medicine (TCM), which sees meridians of life force (chi) running through the body, and aims to optimize health through manipulating the body into maximal alignment.

We are proposing a randomized double-blind placebo-controlled trial to examine the efficacy of acupressure as adjuvant therapy added to antipsychotics in the treatment of patients with schizophrenia.

The goals of this study are twofold:

1. To assess through the highest standards of empirical research whether acupressure can benefit patients with schizophrenia.
2. To furnish data relevant to the possible physiological mechanisms by which acupressure may produce a therapeutic effect.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. DSM-IV diagnosis of schizophrenia or schizoaffective disorder
2. Ages 18 and over
3. Clinical status stable, as reflected by changes in Brief Psychiatric Rating Scale (BPRS) (Overall & Gorham, 1961) of less than 20% during a one month period prior to randomization, and at least one month of drug treatment without change of anti-psychotic drug or dosage.
4. Ability to cooperate with 40-minute sessions

Exclusion criteria

1. Unstable general medical conditions
2. Active bone fracture or other orthopedic problem
3. Skin condition that renders treatment unsafe or painful
4. Active infection in skin or soft tissues, such as cellulitis
5. Solid tissue malignancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

150 participants in 3 patient groups, including a placebo group

Acupressure

Experimental group

Description:

Acupressure adjuvant therapy

Treatment:

Behavioral: Acupressure adjuvant therapy

Placebo acupressure

Placebo Comparator group

Description:

Sham acupressure adjuvant therapy

Treatment:

Behavioral: Acupressure adjuvant therapy

No treatment

No Intervention group

Description:

Wait list group (no treatment)